TipRanks
Advertisement
Advertisement

EXEL Stock Latest News

Exelixis price target raised to $65 from $55 at Citizens
The FlyExelixis price target raised to $65 from $55 at Citizens
3d ago
EXEL
Exelixis price target raised to $51 from $45 at RBC Capital
PremiumThe Fly
Exelixis price target raised to $51 from $45 at RBC Capital
13d ago
EXEL
Exelixis price target lowered to $45 from $46 at RBC Capital
PremiumThe Fly
Exelixis price target lowered to $45 from $46 at RBC Capital
14d ago
EXEL
Exelixis price target raised to $54 from $52 at Truist
PremiumThe Fly
Exelixis price target raised to $54 from $52 at Truist
15d ago
EXEL
Exelixis Rated Hold as Zanzalintinib CRC Outlook Remains Mixed; $54 Price Target Reaffirmed
PremiumRatings
Exelixis Rated Hold as Zanzalintinib CRC Outlook Remains Mixed; $54 Price Target Reaffirmed
1M ago
EXEL
FDA-Driven Zanza Delay Keeps Exelixis Fairly Valued, Supporting Willey’s Hold Rating
PremiumRatingsFDA-Driven Zanza Delay Keeps Exelixis Fairly Valued, Supporting Willey’s Hold Rating
1M ago
EXEL
Exelixis risk of rejection ‘low’ despite zanzalintinib delay, says William Blair
Premium
The Fly
Exelixis risk of rejection ‘low’ despite zanzalintinib delay, says William Blair
1M ago
EXEL
FDA Extends Review Timeline for Exelixis Cancer Drug
Premium
Company Announcements
FDA Extends Review Timeline for Exelixis Cancer Drug
1M ago
8K
EXEL
Exelixis says FDA extends review period for zanzalintinib NDA by three months
PremiumThe Fly
Exelixis says FDA extends review period for zanzalintinib NDA by three months
1M ago
EXEL
Adagene announces $2M milestone payment from Exelixis
PremiumThe Fly
Adagene announces $2M milestone payment from Exelixis
1M ago
ADAG
EXEL
Exelixis Secures Key Patent Victory, Extends Exclusivity
PremiumCompany Announcements
Exelixis Secures Key Patent Victory, Extends Exclusivity
2M ago
8K
EXEL
Exelixis says appeals court affirmed ‘key portion’ of 2024 judgment
PremiumThe Fly
Exelixis says appeals court affirmed ‘key portion’ of 2024 judgment
2M ago
EXEL
Trump Trade: U.S. considering new semiconductor tariffs
PremiumThe FlyTrump Trade: U.S. considering new semiconductor tariffs
2M ago
MU
AMD
White House to announce drug pricing deals with biotechs, Bloomberg reports
Premium
The Fly
White House to announce drug pricing deals with biotechs, Bloomberg reports
2M ago
ALKS
ALNY
BMO starts Exelixis at Market Perform into patent cliff
Premium
The Fly
BMO starts Exelixis at Market Perform into patent cliff
2M ago
EXEL
Exelixis initiated with a Market Perform at BMO Capital
PremiumThe Fly
Exelixis initiated with a Market Perform at BMO Capital
2M ago
EXEL
Exelixis Earnings Call: Cabo Strength, Zanza Awaited
PremiumCompany Announcements
Exelixis Earnings Call: Cabo Strength, Zanza Awaited
3M ago
EXEL
Leerink downgrades Exelixis to Market Perform following Q2 results
PremiumThe Fly
Leerink downgrades Exelixis to Market Perform following Q2 results
3M ago
EXEL
Exelixis downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Exelixis downgraded to Market Perform from Outperform at Leerink
3M ago
EXEL
Exelixis Targets Residual Colorectal Cancer With New Phase 3 Trial
PremiumCompany AnnouncementsExelixis Targets Residual Colorectal Cancer With New Phase 3 Trial
3M ago
EXEL
Exelixis price target raised to $51 from $47 at Stifel
Premium
The Fly
Exelixis price target raised to $51 from $47 at Stifel
3M ago
EXEL
Exelixis price target lowered to $52 from $56 at Truist
Premium
The Fly
Exelixis price target lowered to $52 from $56 at Truist
3M ago
EXEL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >